| NCT ID | NCT05425524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chulalongkorn University |
| Condition | Leptospirosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2019-10-01 |
| Primary Completion | 2022-01-19 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2019-10-01 with a primary completion date of 2022-01-19.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
So in management of Leptospirosis patients There really is no another approach to treatment. The importance of the problem was acknowledged by the researchers. As a result, this study was performed in order to The Leptospirosis Care Bundle has been used, and has been proved that its use can reduce the risk of acute renal failure.
Eligibility Criteria
Inclusion Criteria: * age \> 18 years * Suspicious Leptospirosis including body temperature \> 38 celcius, Severe myalgia, and exposure to reservoir hospital of flood water. * Calf muscle tenderness * Conjunctival suffusion * Anuria or oliguria and/or proteinuria * Jaundice * Hemorrhagic manifestations (pulmonary and intestine) * Meningeal irritation * Nausea, vomiting, abdominal pain, diarrhea. * Admitted in hospital Exclusion Criteria: * other infectious disease * pregnancy
Frequently Asked Questions
Who can join the NCT05425524 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Leptospirosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05425524 currently recruiting?
Yes, NCT05425524 is actively recruiting participants. Visit ClinicalTrials.gov or contact Chulalongkorn University to inquire about joining.
Where is the NCT05425524 trial being conducted?
This trial is being conducted at Bangkok, Thailand.
Who is sponsoring the NCT05425524 clinical trial?
NCT05425524 is sponsored by Chulalongkorn University. The trial plans to enroll 300 participants.